QuiVad
My list

Home / Italy / CTI Biopharma Corp

CTI Biopharma Corp

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
Over the whole history, the total peaked at 2.77% on July 27, 2015. The shaded band matches the twelve months of the first chart.

November 30, 2012 today

Open positions

No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.

Follow by RSS

Get the moves on CTI Biopharma Corp by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

163 disclosures on record for this share.
DateFund% of capitalEnd of publication
October 24, 2013The Goldman Sachs Group, Inc.0.61%
October 22, 2013The Goldman Sachs Group, Inc.0.55%
October 17, 2013The Goldman Sachs Group, Inc.0.66%
October 15, 2013The Goldman Sachs Group, Inc.0.70%
October 14, 2013The Goldman Sachs Group, Inc.0.67%
October 9, 2013The Goldman Sachs Group, Inc.0.71%
October 4, 2013The Goldman Sachs Group, Inc.0.85%
October 3, 2013The Goldman Sachs Group, Inc.0.60%
October 2, 2013The Goldman Sachs Group, Inc.0.57%
September 26, 2013Two Sigma Investments, LP0.46%
September 23, 2013Two Sigma Investments, LP0.50%
September 20, 2013Two Sigma Investments, LP0.49%
September 18, 2013Two Sigma Investments, LP0.50%
September 17, 2013Two Sigma Investments, LP0.49%
September 16, 2013Two Sigma Investments, LP0.51%
August 19, 2013Two Sigma Investments, LP0.49%
July 9, 2013Two Sigma Investments, LP0.50%
July 1, 2013The Goldman Sachs Group, Inc.0.35%
June 28, 2013The Goldman Sachs Group, Inc.0.59%
May 31, 2013Two Sigma Investments, LP0.49%
May 10, 2013Two Sigma Investments, LP0.59%
April 25, 2013The Goldman Sachs Group, Inc.0.49%
April 22, 2013The Goldman Sachs Group, Inc.0.53%
April 19, 2013The Goldman Sachs Group, Inc.0.68%
April 17, 2013The Goldman Sachs Group, Inc.0.73%
April 17, 2013Two Sigma Investments, LP0.60%
April 16, 2013The Goldman Sachs Group, Inc.0.80%
April 15, 2013The Goldman Sachs Group, Inc.0.73%
April 12, 2013The Goldman Sachs Group, Inc.1.14%
April 11, 2013The Goldman Sachs Group, Inc.1.28%
April 10, 2013The Goldman Sachs Group, Inc.0.85%
April 3, 2013Two Sigma Investments, LP0.50%
March 28, 2013The Goldman Sachs Group, Inc.0.96%
March 27, 2013The Goldman Sachs Group, Inc.1.04%
March 22, 2013The Goldman Sachs Group, Inc.0.98%
March 1, 2013The Goldman Sachs Group, Inc.1.07%
February 26, 2013The Goldman Sachs Group, Inc.1.17%
February 22, 2013The Goldman Sachs Group, Inc.1.25%
February 20, 2013The Goldman Sachs Group, Inc.1.18%
February 15, 2013The Goldman Sachs Group, Inc.1.23%
February 12, 2013The Goldman Sachs Group, Inc.1.00%
February 8, 2013The Goldman Sachs Group, Inc.0.99%
February 1, 2013The Goldman Sachs Group, Inc.1.01%
January 30, 2013The Goldman Sachs Group, Inc.0.99%
January 25, 2013The Goldman Sachs Group, Inc.1.01%
January 22, 2013The Goldman Sachs Group, Inc.0.94%
January 10, 2013The Goldman Sachs Group, Inc.0.00%
January 9, 2013The Goldman Sachs Group, Inc.1.00%
January 4, 2013The Goldman Sachs Group, Inc.1.38%
December 28, 2012The Goldman Sachs Group, Inc.1.29%

Download 163 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Italy

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, CTI Biopharma Corp, source Consob, data as at June 14, 2017, https://www.quivad.com/action/cti-biopharma-corp?page=3